Skip to main content
logo
OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.410
-0.020 (-1.40%)
At close: Oct 16, 2026, 4:00 PM EDT
1.420
+0.010 (0.71%)
After-hours: Oct 16, 2026, 7:30 PM EDT

OKYO Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
7484435034109
Market Cap Growth
-4.96%96.04%-12.97%47.06%-68.99%46.71%
Enterprise Value
5380424833103
Last Close Price
1.411.611.271.491.325.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
6.006.85-7.77-8.42-16.4036.84
P/TBV Ratio
6.006.85---36.84

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
-----1.08-
Net Debt / Equity Ratio
-1.67-1.670.280.140.89-0.92
Net Debt / EBITDA Ratio
2.422.420.220.050.140.44
Net Debt / FCF Ratio
3.473.470.860.090.240.49
Quick Ratio
2.402.400.370.190.692.65
Current Ratio
2.432.430.400.210.723.17
Return on Equity (ROE)
-263.78%-263.78%---2968.51%-131.55%
Return on Assets (ROA)
-43.09%-43.09%-169.87%-291.87%-173.43%-68.30%
Return on Capital Employed (ROCE)
-68.90%-68.90%127.80%267.90%642.30%-211.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-12.09%-10.59%-10.92%-33.98%-39.41%-5.00%
FCF Yield
-8.03%-7.03%-4.21%-19.16%-22.87%-5.04%
Buyback Yield / Dilution
5.40%5.40%-34.57%-31.84%-47.74%-45.55%
SEC Filings: 10-K · 10-Q